- CH₣2.32bn
- CH₣2.49bn
- €510.78m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 311 | 302 | 363 | 437 | 511 |
Cost of Revenue | |||||
Gross Profit | 227 | 214 | 261 | 305 | 348 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 291 | 253 | 304 | 376 | 436 |
Operating Profit | 19.6 | 49.4 | 58.8 | 61.5 | 74.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 13.6 | 39.9 | 55.5 | 54.8 | 58.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.9 | 37.1 | 51.5 | 46.2 | 47.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 11.9 | 37.1 | 51.5 | 46.2 | 47.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11.9 | 37.1 | 51.5 | 46.2 | 47.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.28 | 1.83 | 2.96 | 2.65 | 2.45 |
Dividends per Share |